US-based digital health platform provider BrightInsight has raised $40m in a Series B funding led by venture capital and private equity company Insight Partners.
Series A investors New Leaf Venture Partners and Eclipse Ventures have also participated in the funding round, which is aimed to ensure the growth and expansion of the company.
The fund will be used by the company to expand the international availability and augmentation of its digital health platform for biopharma and medtech.
Launched in 2018, BrightInsight platform supports and optimises regulated drugs, devices and software through integrated data and actionable insights.
